Physician profile
Scott Ross
NPI 1205829447
$661.98
in general payments reported to CMS, 2019-2025
8 companies · $196 in 2025
The $196 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $66.75 · 2021: $185 · 2022: $16.72 · 2023: $19.17 · 2024: $20.31 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $235.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $159.75 | 2020-2021 | |
| Abbvie INC. | $143.87 | 2025 | |
| Helsinn Therapeutics (U.S.), INC. | $125.00 | 2019 | |
| Sun Pharmaceutical Industries INC. | $107.26 | 2021-2025 | Blu-U |
| Misonix INC | $56.78 | 2021 | |
| Dusa Pharmaceuticals, INC. | $33.19 | 2019 | |
| Biofrontera INC. | $19.41 | 2021 | |
| Merz North America, INC. | $16.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.